Sign In
Buy EVGN
$0.471
-0.0184 (-3.76%)
At Close: Jul 31, 2026
Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil
07:00am, Wednesday, 31'st Jul 2024
Castor seeds from Brazil will be ready for shipment during third quarter of 2024. Castor harvest season in Africa started as planned.
Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split
08:48am, Tuesday, 23'rd Jul 2024
Following the reverse share split, the Company will have approximately 5,079,000 Ordinary Shares issued andoutstanding REHOVOT, Israel , July 23, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants
08:00am, Wednesday, 17'th Jul 2024
More than one dozen novel microbes identified for row crops suffering from extreme weather conditions TEL AVIV and REHOVOT, Israel , July 17, 2024 /PRNewswire/ -- ICL (NYSE: ICL) (TASE: ICL), a leadi
Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat
07:00am, Tuesday, 02'nd Jul 2024
Lavie Bio successfully completed testing of Yalos™ for winter wheat and will commence sales across the US for the 2024-2025 season REHOVOT, Israel , July 2, 2024 /PRNewswire/ -- Lavie Bio Ltd., a le
Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country
07:00am, Tuesday, 25'th Jun 2024
Current castor seed production is expected to support the supply of the new order in 2024, valued at ~ $440K REHOVOT, Israel , June 25, 2024 /PRNewswire/ -- Casterra Ag Ltd ., a subsidiary of Evogen
EverGen Infrastructure Reports Q1 2024 Results
04:00pm, Tuesday, 28'th May 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQX: EVGIF), today reported financial results as at and for Q1 2024. All
Preliminary Phase 1 results show promising trends for BMC128 in combination with nivolumab in refractory cancer patients. Data will be showcased at the 2024 American Society of Clinical Oncology (ASC
Evogene Reports First Quarter 2024 Financial Results
07:00am, Thursday, 23'rd May 2024
Conference call and webcast: today, May 23, 2024, 9:00 am ET Financial and Business Highlights: Q1 2024 revenue: $4.2M vs. $0.6M in Q1 2023; anticipating continued growth in 2024.
EverGen Infrastructure Announces Dates for 2024 First Quarter Financial Results and Conference Call
04:05pm, Wednesday, 22'nd May 2024
VANCOUVER, British Columbia--(BUSINESS WIRE)--EverGen Infrastructure Corp. (“EverGen” or the “Company”) (TSXV: EVGN) (OTCQX: EVGIF), today announced plans to release its 2024 first quarter fin
Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds
07:03am, Tuesday, 21'st May 2024
These agreements are expected to support the production of approximately 500 tons of additional seeds, enabling the completion of standing orders by the end of 2024 and positioning Casterra to fulfil
Evogene Schedules First Quarter 2024 Financial Results Release
07:00am, Thursday, 09'th May 2024
Zoom conference call scheduled for 9:00 AM ET REHOVOT, Israel , May 9, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
07:00am, Tuesday, 16'th Apr 2024
Preliminary data from Biomica's Phase 1 study of BMC128 will be showcased at the conference REHOVOT, Israel , April 16, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company de
Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting
07:00am, Thursday, 11'th Apr 2024
REHOVOT, Israel , April 11, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd.
Finally Foods is financed by the Israeli Innovation Authority (IIA) and The Kitchen Hub, and will be granted a license to utilize Evogene's AI technology REHOVOT, Israel , April 2, 2024 /PRNewswire/ -
Evogene Announces Filing of Annual Report on Form 20-F
09:00am, Thursday, 28'th Mar 2024
REHOVOT, Israel , March 28, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science-based product discovery and
